Skip to main content
. 2017 Dec 12;17(2):2901–2906. doi: 10.3892/mmr.2017.8257

Figure 3.

Figure 3.

Proliferation of LNCaP prostate cancer cells. The Cell Counting kit-8 assay demonstrated that knocking down the androgen receptor using the clustered regularly interspaced short palindromic repeats-associated protein system inhibited prostate cancer cell proliferation. Treatment, LNCaP-Cas9-single-guide RNA-AR230; Control, LNCaP-Cas9-control. OD, optical density.